المؤلفون: Christian U. Blank, Paulien Cornelissen-Steijger, Aida Shahrabi, Oscar Krijgsman, Petra Ross-Macdonald, Daniel S. Peeper, John B. A. G. Haanen, Martin Del Castillo Velasco-Herrera, Kristel Kemper, Maarten A. Ligtenberg, Sofia Ibanez Molero, David W. Vredevoogd, Julia Boshuizen, Roelof J.C. Kluin, Ji-Ying Song, Thomas Kuilman, Elisa A. Rozeman, Beaunelle de Bruijn, David J. Adams

المصدر: Clinical Cancer Research. 27:5389-5400

مصطلحات موضوعية: Cancer Research, business.industry, Melanoma, Programmed Cell Death 1 Receptor, Cell, RNA, medicine.disease, Immune checkpoint, Blockade, Transplantation, Mice, medicine.anatomical_structure, Oncology, CTLA-4, Tumor Microenvironment, Cancer research, Animals, Humans, Medicine, Cytotoxic T cell, CTLA-4 Antigen, business, Immune Checkpoint Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f4efae16e2251e152c52de002875ffTest
https://doi.org/10.1158/1078-0432.ccr-20-4218Test

المؤلفون: Céleste Lebbé, Ines Pires da Silva, Irene L.M. Reijers, Megan Lyle, Alexander M. Menzies, Alison Weppler, Shahneen Sandhu, Camille L. Gerard, Matteo S. Carlino, Joanna Mangana, Douglas B. Johnson, Patricio Serra-Bellver, Oliver Klein, James R. Patrinely, Andrew Haydon, Tasnia Ahmed, Olivier Michielin, Khang Nguyen, Claudia Trojaniello, Paul Lorigan, Allison Betof Warner, Dan Stout, Clara Allayous, Christian U. Blank, Paolo A. Ascierto, Lisa Zimmer, Serigne Lo, Georgina V. Long

المصدر: The Lancet Oncology. 22:836-847

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Positron Emission Tomography Computed Tomography, Internal medicine, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Progression-free survival, Neoplasm Metastasis, Immune Checkpoint Inhibitors, Melanoma, Aged, Retrospective Studies, business.industry, Retrospective cohort study, Middle Aged, medicine.disease, Progression-Free Survival, Nivolumab, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9178dd6e7066c6eafdc578a3589333b7Test
https://doi.org/10.1016/s1470-2045Test(21)00097-8

المؤلفون: Prachi Bhave, Tasnia Ahmed, Serigne N Lo, Alexander Shoushtari, Anne Zaremba, Judith M Versluis, Joanna Mangana, Michael Weichenthal, Lu Si, Thierry Lesimple, Caroline Robert, Claudia Trojanello, Alexandre Wicky, Richard Heywood, Lena Tran, Kathleen Batty, Florentia Dimitriou, Anna Stansfeld, Clara Allayous, Julia K Schwarze, Meghan J Mooradian, Oliver Klein, Inderjit Mehmi, Rachel Roberts-Thomson, Andrea Maurichi, Hui-Ling Yeoh, Adnan Khattak, Lisa Zimmer, Christian U Blank, Egle Ramelyte, Katharina C Kähler, Severine Roy, Paolo A Ascierto, Olivier Michielin, Paul C Lorigan, Douglas B Johnson, Ruth Plummer, Celeste Lebbe, Bart Neyns, Ryan Sullivan, Omid Hamid, Mario Santinami, Grant A McArthur, Andrew M Haydon, Georgina V Long, Alexander M Menzies, Matteo S Carlino

المساهمون: Clinical sciences, Laboratory of Molecular and Medical Oncology, Internal Medicine, Faculty of Medicine and Pharmacy, Medical Oncology

المصدر: Bhave, P, Ahmed, T, Lo, S N, Shoushtari, A, Zaremba, A, Versluis, J M, Mangana, J, Weichenthal, M, Si, L, Lesimple, T, Robert, C, Trojanello, C, Wicky, A, Heywood, R, Tran, L, Batty, K, Dimitriou, F, Stansfeld, A, Allayous, C, Schwarze, J K, Mooradian, M J, Klein, O, Mehmi, I, Roberts-Thomson, R, Maurichi, A, Yeoh, H L, Khattak, A, Zimmer, L, Blank, C U, Ramelyte, E, Kähler, K C, Roy, S, Ascierto, P A, Michielin, O, Lorigan, P C, Johnson, D B, Plummer, R, Lebbe, C, Neyns, B, Sullivan, R, Hamid, O, Santinami, M, McArthur, G A, Haydon, A M, Long, G V, Menzies, A M & Carlino, M S 2022, ' Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma ', Journal for ImmunoTherapy of Cancer, vol. 10, no. 7, e004668 . https://doi.org/10.1136/jitc-2022-004668Test

مصطلحات موضوعية: Pharmacology, Cancer Research, Skin Neoplasms, Manchester Cancer Research Centre, ResearchInstitutes_Networks_Beacons/mcrc, Immunology, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, oncology, Molecular Medicine, Immunology and Allergy, Humans, CTLA-4 Antigen, Immunotherapy, immunotherapy, Prospective Studies, Melanoma, Retrospective Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b5a9d00012b0583c371b3485e31ff2Test
https://pubmed.ncbi.nlm.nih.gov/35793872Test

المؤلفون: Paulien Kaptein, Celia Jacoberger-Foissac, Petros Dimitriadis, Paula Voabil, Marjolein de Bruijn, Simone Brokamp, Irene Reijers, Judith Versluis, Gahyathiri Nallan, Hannah Triscott, Elizabeth McDonald, Joshua Tay, Georgina V. Long, Christian U. Blank, Daniela S. Thommen, Michele W.L. Teng

المصدر: Science Translational Medicine, 14(642). AMER ASSOC ADVANCEMENT SCIENCE

مصطلحات موضوعية: Mice, Programmed Cell Death 1 Receptor, Animals, Humans, Interleukin-2, CTLA-4 Antigen, General Medicine, CD8-Positive T-Lymphocytes, Melanoma, Neoadjuvant Therapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6676795225993de96cda1c9757ccd80fTest
https://doi.org/10.1126/scitranslmed.abj9779Test

المؤلفون: Elisa A. Rozeman, Judith M. Versluis, Ruben Moritz, Sofie Wilgenhof, Johannes V. van Thienen, John B.A.G. Haanen, Michel M. van de Heuvel, Christian U. Blank, Huub H. van Rossum

المصدر: Clinica chimica acta; international journal of clinical chemistry. 533

مصطلحات موضوعية: Skin Neoplasms, L-Lactate Dehydrogenase, Biochemistry (medical), Clinical Biochemistry, Programmed Cell Death 1 Receptor, General Medicine, S100 Calcium Binding Protein beta Subunit, Prognosis, Biochemistry, Antibodies, Biomarkers, Tumor, Humans, Prospective Studies, Melanoma, Retrospective Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a442d4da402e3741825f223a108b67Test
https://pubmed.ncbi.nlm.nih.gov/35709988Test

المؤلفون: Maurits L. van Montfoort, Daniel J. Vis, Kees Hendricksen, Nick van Dijk, Laura A. Smit, Michiel S. van der Heijden, Henk G. van der Poel, Maries van den Broek, Christian U. Blank, Annemarie Bruining, Yoni Lubeck, Lodewyk F. A. Wessels, Dennis Peters, Pia Kvistborg, Karina Silina, Ton N. Schumacher, Charlotte van Rooijen, Karolina Sikorska, Erik Hooijberg, Annegien Broeks, Bas W.G. van Rhijn, Alberto Gil-Jimenez, Jeantine M de Feijter, Thierry N. Boellaard

المساهمون: University of Zurich, van der Heijden, Michiel S, Graduate School

المصدر: Nature medicine, 26(12), 1839-1844. Nature Publishing Group

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 610 Medicine & health, Ipilimumab, 10263 Institute of Experimental Immunology, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, CTLA-4 Antigen, Stage (cooking), Adverse effect, Aged, Neoplasm Staging, business.industry, Antibodies, Monoclonal, General Medicine, Immunotherapy, Middle Aged, Clinical trial, Nivolumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, 570 Life sciences, biology, Female, Urothelium, business, medicine.drug

وصف الملف: 2020_van_Dijk_Nat_Med.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0413d513e2c90df2d190163c39a4236dTest
http://www.scopus.com/inward/record.url?scp=85092396181&partnerID=8YFLogxKTest

المؤلفون: Sanne Patiwael, Christian U. Blank, Ton N. Schumacher, Antoni Ribas, John B. A. G. Haanen, Anastasia Gangaev, Daisy Philips, Dirk Schadendorf, Joost H. van den Berg, Maartje W. Rohaan, Bastian Schilling, Elisa A. Rozeman, Pia Kvistborg, Olga I. Isaeva

المصدر: Proc Natl Acad Sci U S A
Proceedings of the National Academy of Sciences of the United States of America, vol 118, iss 43

مصطلحات موضوعية: Male, Receptors, Antigen, T-Cell, alpha-beta, Programmed Cell Death 1 Receptor, Medizin, Epitopes, T-Lymphocyte, CD8-Positive T-Lymphocytes, Lymphocyte Activation, Epitope, Cohort Studies, Epitopes, melanoma-reactive CD8 T cells, Receptors, PD-1, 80 and over, Cytotoxic T cell, CTLA-4 Antigen, Hepatitis A Virus Cellular Receptor 2, Immune Checkpoint Inhibitors, Melanoma, Cancer, alpha-beta, Aged, 80 and over, Multidisciplinary, Middle Aged, Biological Sciences, medicine.anatomical_structure, 5.1 Pharmaceuticals, Antigen, Female, Development of treatments and therapeutic interventions, medicine.symptom, Melanoma-Specific Antigens, Adult, Receptors, CXCR5, T cell, In Vitro Techniques, Clinical Research, medicine, Humans, Aged, business.industry, Compartment (ship), T-Cell, medicine.disease, CXCR5, Blockade, Kinetics, T-Lymphocyte, Mechanism of action, CTLA-4, Cancer research, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994323e563648a11d8ffa0127b701604Test
https://doi.org/10.1073/pnas.2102849118Test

المؤلفون: Thomas Eigentler, Cindy Franklin, Anja Gesierich, Claus Garbe, Sebastian Haferkamp, James Larkin, Sophia Kreft, Paul Lorigan, Bastian Schilling, Sara Valpione, Selma Ugurel, Jochen Utikal, Dirk Schadendorf, Christian U. Blank

المصدر: European Journal of Cancer. 116:207-215

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Targeted therapy, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Adverse effect, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, Salvage Therapy, business.industry, Immunotherapy, Middle Aged, medicine.disease, Confidence interval, Nivolumab, Treatment Outcome, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f33bef3ecdaf233f4184cbdb0bbc1eTest
https://doi.org/10.1016/j.ejca.2019.05.015Test

المؤلفون: Ieva Kurilova, Regina G. H. Beets-Tan, Ferry Lalezari, S.G. Drago, A. Delli Pizzi, J.B.A.G. Haanen, Chintan Parmar, Maartje W. Rohaan, Stefano Trebeschi, Doenja M. J. Lambregts, Elisa A. Rozeman, Egbert F. Smit, Nicolai Juul Birkbak, Koen J. Hartemink, A.M. Cǎlin, Charles Swanton, Christian U. Blank, Hugo J.W.L. Aerts

المساهمون: Promovendi ODB, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Faculteit FHML Centraal

المصدر: Trebeschi, S, Drago, S G, Birkbak, N J, Kurilova, I, Cǎlin, A M, Delli Pizzi, A, Lalezari, F, Lambregts, D M J, Rohaan, M W, Parmar, C, Rozeman, E A, Hartemink, K J, Swanton, C, Haanen, J B A G, Blank, C U, Smit, E F, Beets-Tan, R G H & Aerts, H J W L 2019, ' Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers ', Annals of Oncology, vol. 30, no. 6, mdz108, pp. 998-1004 . https://doi.org/10.1093/annonc/mdz108Test
Technology in Cancer Research & Treatment
Annals of Oncology, 30(6), 998-1004. Oxford University Press
Annals of Oncology

مصطلحات موضوعية: 0301 basic medicine, Oncology, SELECTION, Lung Neoplasms, BLOCKADE, medicine.medical_treatment, FEATURES, Programmed Cell Death 1 Receptor, 0302 clinical medicine, Cancer immunotherapy, Neoplasms, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, PD-1, Melanoma, Letter to the Editor, DOCETAXEL, RISK, Special Collection on Current Technologies in Targeted Cancer Immunotherapies, Hematology, Prognosis, artificial intelligence, 3. Good health, Survival Rate, machine learning, radiomics, 030220 oncology & carcinogenesis, Biomarker (medicine), immunotherapy, SENSITIVITY, Algorithms, EXPRESSION, medicine.medical_specialty, CELL LUNG-CANCER, medical imaging, 03 medical and health sciences, Onco-Immunology, Predictive Value of Tests, Internal medicine, medicine, Medical imaging, Immunologic Factors, Humans, Lung cancer, SIGNATURES, Noninvasive biomarkers, business.industry, Cancer, NIVOLUMAB, Immunotherapy, medicine.disease, Original articles, Editor's Choice, 030104 developmental biology, response prediction, business, Tomography, X-Ray Computed, Biomarkers, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd03537dc5d67fb40abb417868a1cc9Test
https://doi.org/10.1093/annonc/mdz108Test

المؤلفون: Giampaolo Tortora, Bernard A. Fox, Ramy Ibrahim, Christian U. Blank, Alexander M.M. Eggermont, Michael Lahn, Anna Maria Di Giacomo, Michele Maio, R. Bryan Bell, Andrea Necchi

المساهمون: Maio, M., Blank, C., Necchi, A., Di Giacomo, A. M., Ibrahim, R., Lahn, M., Fox, B. A., Bell, R. B., Tortora, G., Eggermont, A. M. M.

مصطلحات موضوعية: 0301 basic medicine, Oncology, PD-L1, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Neoadjuvant trials, Biomarkers, Bladder cancer, CTLA-4, Head and neck cancer, Immunotherapy, Melanoma, Pancreatic cancer, PD-1, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Internal medicine, Tumor Microenvironment, medicine, Humans, CTLA-4 Antigen, Immune Checkpoint Inhibitors, Lymph node, business.industry, Cancer, medicine.disease, Head and neck squamous-cell carcinoma, Neoadjuvant Therapy, 030104 developmental biology, medicine.anatomical_structure, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Adenocarcinoma, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eba278732050d946d514842ba857bccaTest
https://hdl.handle.net/11365/1233299Test